The global intravascular lithotripsy market was valued at USD 1.01 billion in 2025 and is projected to reach USD 4.19 billion by 2035, growing at a 15.3% CAGR from 2026 to 2035, according to SNS Insider. Intravascular lithotripsy, or IVL, uses catheter-generated pressure waves to fracture vascular calcium deposits while limiting damage to surrounding soft tissue. Demand is being supported by heavily calcified coronary and peripheral artery disease, wider use of minimally invasive cardiac procedures, and calcium modification before angioplasty and stenting. IVL catheters and balloons led products with about 56.0% of the 2025 market, coronary IVL led types with 58.0%, coronary artery disease led applications with roughly 52.0%, and hospitals led end users with around 66.0%. North America was the largest regional market, accounting for about 58.0% of revenue, while Asia Pacific was identified as the fastest-growing region. The report highlights expansion into peripheral, femoro-popliteal and below-the-knee procedures, as well as advances in forward-firing catheters and disposable systems.